Enterococcus faecium Unknown Status Phase 4 Trials for Gut -Microbiota / Irritable Bowel Syndrome (IBS) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Unknown Status | Treatment | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT04074421 | Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D |